Day Pitney remains committed to providing quality legal counsel, while protecting our clients and employees, and transforming our communities into more just, equal and equitable spaces. For more information, please visit our COVID-19 Resource Center | Racial Justice and Equity Task Force.

Insights

Publications Events Blogs

Co-author, "Viewpoint: Advocating for Biosimilar Approval Standards under BPCI," Pharmaceutical Technology, Vol 35, Issue 6, June 2011

June 1, 2011
Day Pitney Author(s) Elizabeth P. Retersdorf